“Novel In-Office Injectables for the Dermatology–Rheumatology Patient: Botulinum Toxin, Sodium Thiosulfate, and Hyaluronidase” (2026) Canadian Dermatology Today, 7(3), pp. 4–10. doi:10.58931/cdt.2026.73167.